Business Description
Incyte Corporation is a biopharmaceutical company founded in 1991 and headquartered in Wilmington, Delaware, that discovers, develops, and sells treatments for serious diseases across the United States, Europe, Canada, and Japan. The company focuses primarily on cancers and immune-related conditions, with a portfolio of approved medicines targeting blood cancers, lymphomas, and graft-versus-host disease, alongside a growing pipeline of clinical-stage therapies addressing solid tumors, skin conditions, and rare diseases. Incyte works with partners including Novartis, Lilly, Syndax, and Genmab to advance its research, and distributes its products through specialty pharmacies, hospital pharmacies, and distributors.
